Aerosol Delivery of Polyelectrolyte Surfactant—Antimicrobial Nanoparticles to the Lungs
Pharmaceutical Research · 2026
DOI: 10.1007/s11095-025-03985-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutical Research, 2026. Verfasst von Yadiel Varela Soler und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ, 08854, USA. Hauptthemen laut MEDLINE: Lung, Nanoparticles, Surface-Active Agents, Polyelectrolytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Jersey Health Foundation, National Institute of Allergy and Infectious Diseases, NIGMS NIH HHS.
Abstract (Originalsprache)
Background
Lung infections affect over 80% of adults with cystic fibrosis, with Pseudomonas aeruginosa being a leading pathogen. Although antibiotics are frequently nebulized as standard treatments, the physicochemical environment of the diseased lung often limits their diffusion and overall effectiveness. Our previous studies showed polyelectrolyte surfactants (PS) to be a promising delivery system for cationic antimicrobials in vitro . This study seeks to expand that knowledge by evaluating their potential for nebulized delivery.
Methods
To achieve this, we evaluated their size and antimicrobial activity following nebulization; in vitro toxicity against epithelial cells and erythrocytes; and biodistribution and expression of inflammation markers following administration to healthy mice.
Results
The nanoparticle formulation exhibited a mucolytic effect on an artificial mucus model of cystic fibrosis mucus. Following nebulization, nanoparticles retained both their size and biological activity. Additionally, they displayed no observable toxicity in vitro against either human lung epithelial cells or erythrocytes; instead, epithelial cells treated with PS-based nanoparticles showed increased cell viability. Following administration of these formulations to mice via inhalation, over 70% of the recovered nanoparticles were retained in the lungs 24 h after treatment, with a small fraction being uniformly distributed to other tissues. A screen of key inflammatory cytokines revealed that inhalation treatment led to a slight increase of IL-6 in the liver and IL-18 in the spleen. These increases seem to be consistent with a minor inflammatory response.
Conclusion
Overall, the results suggest that PS are a promising nanotechnology for the pulmonary delivery of cationic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical and Biochemical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
- Department of Biomedical Engineering, Rutgers University, Piscataway, NJ, 08854, USA.
- University of Puerto Rico, Mayaguez, PR, 00680, USA.
- Department of Environmental Sciences, Rutgers University, New Brunswick, NJ, 08901, USA.
- Department of Pharmaceutics, Rutgers University, Piscataway, NJ, 08854, USA.
- Graplon Technologies, LLC, Langhorne, PA, 19047, USA.
Förderung
- New Jersey Health Foundation
- National Institute of Allergy and Infectious Diseases
- NIGMS NIH HHS
- National Science Foundation
- NIAID NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institute of General Medical Sciences
Zitieren
APA
Varela Soler, Y., Padilla-López, A. S., Rao, S., Calderon, L., Mainelis, G., Garbuzenko, O., Minko, T., Devore, D. I., & Roth, C. M. (2026). Aerosol Delivery of Polyelectrolyte Surfactant—Antimicrobial Nanoparticles to the Lungs. Pharmaceutical Research. https://doi.org/10.1007/s11095-025-03985-2
Vancouver
Varela Soler Y, Padilla-López AS, Rao S, Calderon L, Mainelis G, Garbuzenko O, et al. Aerosol Delivery of Polyelectrolyte Surfactant—Antimicrobial Nanoparticles to the Lungs. Pharmaceutical Research. 2026. doi:10.1007/s11095-025-03985-2
BibTeX
@article{VarelaSoler2026,
author = {Varela Soler, Yadiel and Padilla-López, Amanda S and Rao, Sughosha and Calderon, Leonardo and Mainelis, Gediminas and Garbuzenko, Olga and Minko, Tamara and Devore, David I and Roth, Charles M},
title = {Aerosol Delivery of Polyelectrolyte Surfactant—Antimicrobial Nanoparticles to the Lungs},
journal = {Pharmaceutical Research},
year = {2026},
doi = {10.1007/s11095-025-03985-2}
}
EUVIMED